{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:45:44Z","timestamp":1790045144702,"version":"4.0.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Although fecal microbiota transplantation (FMT) from healthy donors has been shown to have hypoglycemic effects in animal models of diabetes, its clinical impact in patients with abnormal blood glucose metabolism is unclear, especially in southern Chinese populations. The aim of this study was to investigate the feasibility and efficacy of washed microbiota transplantation (WMT) in the treatment of abnormal blood glucose metabolism in a population in southern China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical data of patients with different indications who received 1-3 treatments of WMT were retrospectively collected. The changes of blood glucose, blood lipids, blood pressure, liver function and blood routine before and after WMT were compared, such as fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), systolic blood pressure (SBP), white blood cells (WBC), lymphocytes (LY) and platelets (PLT), etc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 195 patients were included in the First Affiliated Hospital of Guangdong Pharmaceutical University, including 20 patients with high blood glucose and 175 patients with normal blood glucose. WMT has a significant effect in reducing short term blood glucose level (FBG) in patients with high blood glucose (p &amp;lt; 0.05). The fasting blood glucose (FBG) of 72.22% of patients with high blood glucose decreased to normal in a short term (about 1 month) (p &amp;lt; 0.001); In the medium term (about 2 months), there was a significant hypolipidemic (TG) (p = 0.043) effect, long term (about 6 months) significant blood pressure lowering (SBP, p = 0.048) effect. Overall, WMT significantly reduced the risk of high risk classes of Atherosclerotic Cardiovascular Disease (ASCVD) in the short term (p = 0.029) and medium term (p = 0.050).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>WMT can significantly improve blood glucose in patients with high blood glucose, and there is no long-term elevated risk of blood glucose and ASCVD. FBG levels were significantly reduced in both the short and medium term in patients with high blood glucose treated with WMT. Therefore, the regulation of gut microbiota by WMT may provide a new clinical approach for the treatment of abnormal blood glucose metabolism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.985636","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:32:35Z","timestamp":1663939955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Washed microbiota transplantation improves patients with high blood glucose in South China"],"prefix":"10.3389","volume":"13","author":[{"given":"Lei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0678","article-title":"Diagnosed and undiagnosed diabetes prevalence by county in the U.S., 1999\u20132012","volume":"39","author":"Dwyer-Lindgren","year":"2016","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.19538\/j.nk2021080106","article-title":"Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part 1)","volume":"41","year":"2021","journal-title":"Chin J of Pract Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e3158","DOI":"10.1002\/dmrr.3158","article-title":"Society: Standards of medical care for type 2 diabetes in China 2019","volume":"35","author":"Jia","year":"2019","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(17)31537-4","article-title":"Diabetes: a dynamic disease","volume":"389","author":"The","year":"2017","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108086","article-title":"Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: Results from the international diabetes federation diabetes atlas, 9th edition","volume":"162","author":"Saeedi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868150-00005","article-title":"New drugs for type 2 diabetes mellitus","volume":"68","author":"Krentz","year":"2008","journal-title":"Drugs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: An integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2017.08.038","article-title":"Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals","volume":"111","author":"Sedighi","year":"2017","journal-title":"Microb. Pathog."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2012.153","article-title":"An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice","volume":"7","author":"Fei","year":"2013","journal-title":"ISME J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.07.007","article-title":"Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children","volume":"2","author":"Zhang","year":"2015","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising treatment for type 2 diabetes: Fecal microbiota transplantation reverses insulin resistance and impaired islets","volume":"9","author":"Wang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2810","article-title":"Methods and reporting studies assessing fecal microbiota transplantation","volume":"167","author":"Bafeta","year":"2017","journal-title":"Ann Internal Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/gutjnl-2019-318320","article-title":"Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time","volume":"69","author":"de Groot","year":"2020","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1353848","article-title":"The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis","volume":"8","author":"Qazi","year":"2017","journal-title":"Gut Microbes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.006","article-title":"Effects of fecal microbiota transplantation with oral capsules in obese patients","volume":"18","author":"Allegretti","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000494252","article-title":"An open-labeled study on fecal microbiota transfer in irritable bowel syndrome patients reveals improvement in abdominal pain associated with the relative abundance of akkermansia muciniphila","volume":"100","author":"Cruz-Aguliar","year":"2019","journal-title":"Digestion"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.117","article-title":"Fecal microbiota transplantation: Effectiveness, complexities, and lingering concerns","volume":"7","author":"Pamer","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: Clinical findings, animal studies and in vitro screening","volume":"11","author":"Zhang","year":"2020","journal-title":"Protein Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000954","article-title":"Fecal microbiota transplantation-standardization study: Nanjing consensus on methodology of washed microbiota transplantation","volume":"133","author":"Zhang","year":"2020","journal-title":"Chin Med J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1136\/gutjnl-2018-316818","article-title":"The use of fecal microbiota transplant as treatment for recurrent or refractory clostridium difficile infection and other potential indications: Joint British society of gastroenterology (BSG) and healthcare infection society (HIS) guidelines","volume":"67","author":"Mullish","year":"2018","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2018.1527177","article-title":"Practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: ESC\/ESH task force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3760\/cma.j.issn.0253-3758.2018.01.004","article-title":"Chinese Guidelines for the prevention of cardiovascular diseases","volume":"46","year":"2018","journal-title":"Chin J Cardiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1671-7368.2020.02.003","article-title":"Guideline for primary care of obesity: Practice version (2019)","volume":"19","year":"2020","journal-title":"Chin J Gen Pract"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2018.1536646","article-title":"Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota","volume":"59","author":"Nie","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00041.2015","article-title":"Linking gut microbiota and inflammation to obesity and insulin resistance","volume":"31","author":"Saad","year":"2016","journal-title":"Physiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physiolgenomics.00194.2006","article-title":"A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human","volume":"29","author":"Salek","year":"2007","journal-title":"Physiol Genomics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79214","article-title":"Engineering the gut microbiota to treat hyperammonemia","volume":"125","author":"Shen","year":"2015","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13561","article-title":"Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT)","volume":"21","author":"Lee","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European Consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/gutjnl-2019-320438","article-title":"Mediterranean Diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake","volume":"69","author":"Meslier","year":"2020","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2020.08.041","article-title":"Effects of diet-modulated autologous fecal microbiota transplantation on weight regain","volume":"160","author":"Rinott","year":"2021","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PloS Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1293224","article-title":"Fecal microbiota transplantation in metabolic syndrome: History, present and future","volume":"8","author":"de Groot","year":"2017","journal-title":"Gut Microbes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11892-019-1180-z","article-title":"Fecal microbiota transplantation: A future therapeutic option for Obesity\/Diabetes","volume":"19","author":"Aron-Wisnewsky","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1038\/s41467-018-07359-8","article-title":"Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells","volume":"9","author":"Burrello","year":"2018","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.3390\/ijms19123720","article-title":"Causal relationship between diet-induced gut microbiota changes and diabetes: A novel strategy to transplant faecalibacterium prausnitzii in preventing diabetes","volume":"19","author":"Ganesan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jconrel.2018.10.003","article-title":"Reducing inflammation through delivery of lentivirus encoding for anti-inflammatory cytokines attenuates neuropathic pain after spinal cord injury","volume":"290","author":"Park","year":"2018","journal-title":"J Controlled Release"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.827107","article-title":"Effect of washed microbiota transplantation on patients with dyslipidemia in south China","volume":"13","author":"Liang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.679624","article-title":"Washed microbiota transplantation lowers blood pressure in patients with hypertension","volume":"11","author":"Zhong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.928785","article-title":"Beneficial effects of repeated washed microbiota transplantation in children with autism","volume":"10","author":"Pan","year":"2022","journal-title":"Front Pediatr"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01341","article-title":"Fecal microbial transplantation and its potential application in cardiometabolic syndrome","volume":"10","author":"Leshem","year":"2019","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161174","article-title":"Systematic review: Adverse events of fecal microbiota transplantation","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10081006","article-title":"Metagenomics-based analysis of the age-related cumulative effect of antibiotic resistance genes in gut microbiota","volume":"10","author":"Wu","year":"2021","journal-title":"Antibiotics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010039","article-title":"Integrated multi-omics for novel aging biomarkers and antiaging targets","volume":"12","author":"Wu","year":"2022","journal-title":"Biomolecules"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2020.1764488","article-title":"Probiotics supplementation improves hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes mellitus: An update of meta-analysis","volume":"61","author":"Liang","year":"2021","journal-title":"Crit Rev Food Sci Nutr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.985636\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:32:42Z","timestamp":1663939962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.985636\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":55,"alternative-id":["10.3389\/fendo.2022.985636"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.985636","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"985636"}}